Bone Marrow TransplantationHematologic DiseasesAnemia, Sickle CellBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityMice, Inbred C57BLCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceImmune SystemCombined Modality TherapyRadiation ChimeraTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsT-LymphocytesTreatment OutcomeBone Marrow ExaminationLeukemia, Myeloid, AcuteGraft RejectionRemission InductionHematologic NeoplasmsImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsGraft vs Host ReactionLymphocyte DepletionLeukemia, MyeloidAcute DiseaseStem Cell TransplantationHeart TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionSevere Combined ImmunodeficiencyMice, Inbred BALB CHLA AntigensImmune ToleranceSpleenChimeraSurvival AnalysisColony-Forming Units AssayRetrospective StudiesMyelodysplastic SyndromesLung TransplantationCyclosporineLymphocyte TransfusionBone DensityCell DifferentiationActuarial AnalysisFlow CytometryCells, CulturedLeukocyte CountNuclear FamilyFollow-Up StudiesOrgan TransplantationAntineoplastic Combined Chemotherapy ProtocolsMice, KnockoutCarmustinePancytopeniaCytomegalovirus InfectionsGraft vs Tumor EffectGraft vs Leukemia EffectSurvival RateCytarabineBone ResorptionGranulocyte Colony-Stimulating FactorLymphomaMelphalanDisease-Free SurvivalDisease Models, AnimalEtoposideMultiple MyelomaInfectionImmunophenotypingLymphocyte ActivationAntibodies, Monoclonal